+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Vaccine Development and Infectious Disease Prevention · Registering as Listener

ICVDIDP
📅 15 – 16 Dec 2026 📍 Manila, Philippines 👥 Standard / Physical Participation
Listener Registration From
$150
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Vaccine Development and Infectious Disease Prevention
ModeStandard / Physical
ParticipationListener
Registration fee$150.00
Bank charges (5.8%)$8.70
Total payable $158.70

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on the latest advancements in vaccine technology and development processes. It aims to explore novel approaches and methodologies that enhance vaccine efficacy and accessibility.

This session will delve into the design, implementation, and outcomes of clinical trials for new vaccines. Participants will discuss challenges and best practices in evaluating vaccine safety and effectiveness.

This track aims to elucidate the immunological responses to various infectious agents. It will cover topics such as immune evasion strategies employed by pathogens and the role of host immunity in disease outcomes.

This session will examine effective public health interventions aimed at preventing infectious diseases. Discussions will include vaccination campaigns, health education, and community engagement strategies.

This track will highlight the development of vaccines targeting newly emerging infectious diseases. It will focus on the rapid response mechanisms and innovative technologies used in vaccine creation.

This session will explore the biological characteristics of various pathogens and how these traits influence vaccine design. Participants will discuss the implications of pathogen biology on vaccine efficacy and safety.

This track will focus on strategies for preventing and responding to infectious disease outbreaks. It will cover surveillance systems, rapid response frameworks, and the role of vaccines in outbreak control.

This session will address the critical aspects of vaccine safety and the factors influencing public perception. Discussions will include risk communication, misinformation, and strategies to enhance vaccine confidence.

This track will explore the use of disease modeling and predictive analytics in understanding infectious disease dynamics. Participants will discuss how these tools can inform vaccine development and public health interventions.

This session will highlight the importance of international collaboration in vaccine research and development. It will focus on partnerships between governments, academia, and industry to address global health challenges.

This track will examine the ethical implications surrounding vaccine research and deployment. Discussions will include informed consent, equitable access, and the responsibilities of researchers and policymakers.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED